News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
507,183 Results
Type
Article (37255)
Company Profile (148)
Press Release (469780)
Multimedia
Podcasts (72)
Webinars (11)
Section
Business (150166)
Career Advice (1546)
Deals (28915)
Drug Delivery (107)
Drug Development (69732)
Employer Resources (127)
FDA (11842)
Job Trends (11353)
News (267923)
Policy (29477)
Tag
Academia (1961)
Accelerated approval (4)
Adcomms (21)
Allergies (74)
Alliances (46603)
ALS (68)
Alzheimer's disease (1195)
Antibody-drug conjugate (ADC) (115)
Approvals (11832)
Artificial intelligence (204)
Autoimmune disease (20)
Automation (9)
Bankruptcy (277)
Best Places to Work (8852)
BIOSECURE Act (19)
Biosimilars (96)
Biotechnology (75)
Bladder cancer (60)
Brain cancer (30)
Breast cancer (215)
Cancer (1815)
Cardiovascular disease (146)
Career advice (1304)
Career pathing (23)
CAR-T (116)
Cell therapy (325)
Cervical cancer (16)
Clinical research (56713)
Collaboration (771)
Compensation (456)
Complete response letters (25)
COVID-19 (2541)
CRISPR (39)
C-suite (186)
Cystic fibrosis (69)
Data (1715)
Decentralized trials (1)
Denatured (20)
Depression (38)
Diabetes (239)
Diagnostics (4080)
Digital health (10)
Diversity (4)
Diversity, equity & inclusion (35)
Drug discovery (101)
Drug pricing (109)
Drug shortages (31)
Duchenne muscular dystrophy (87)
Earnings (55278)
Editorial (40)
Employer branding (17)
Employer resources (113)
Events (67797)
Executive appointments (535)
FDA (12804)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (545)
Gene editing (87)
Generative AI (15)
Gene therapy (271)
GLP-1 (748)
Government (4316)
Grass and pollen (5)
Guidances (45)
Healthcare (12534)
Huntington's disease (19)
IgA nephropathy (27)
Immunology and inflammation (100)
Indications (27)
Infectious disease (2685)
Inflammatory bowel disease (105)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (85)
Interviews (267)
IPO (12404)
IRA (44)
Job creations (2902)
Job search strategy (1127)
Kidney cancer (7)
Labor market (23)
Layoffs (365)
Leadership (13)
Legal (7841)
Liver cancer (58)
Lung cancer (261)
Lymphoma (128)
Machine learning (7)
Management (39)
Manufacturing (283)
MASH (62)
Medical device (6530)
Medtech (6533)
Mergers & acquisitions (16987)
Metabolic disorders (652)
Multiple sclerosis (58)
NASH (21)
Neurodegenerative disease (79)
Neuropsychiatric disorders (27)
Neuroscience (1642)
NextGen: Class of 2025 (4274)
Non-profit (2984)
Now hiring (11)
Obesity (362)
Opinion (221)
Ovarian cancer (59)
Pain (69)
Pancreatic cancer (68)
Parkinson's disease (125)
Partnered (13)
Patents (201)
Patient recruitment (68)
Peanut (39)
People (41019)
Pharmaceutical (71)
Pharmacy benefit managers (16)
Phase I (16903)
Phase II (24735)
Phase III (19690)
Pipeline (1016)
Policy (145)
Postmarket research (2233)
Preclinical (7103)
Press Release (42)
Prostate cancer (90)
Psychedelics (30)
Radiopharmaceuticals (235)
Rare diseases (317)
Real estate (4087)
Recruiting (54)
Regulatory (19256)
Reports (23)
Research institute (1808)
Resumes & cover letters (226)
Rett syndrome (4)
RNA editing (3)
RSV (47)
Schizophrenia (73)
Series A (94)
Series B (47)
Service/supplier (6)
Sickle cell disease (46)
Special edition (9)
Spinal muscular atrophy (147)
Sponsored (20)
Startups (2654)
State (2)
Stomach cancer (13)
Supply chain (65)
Tariffs (42)
The Weekly (50)
Vaccines (735)
Venture capitalists (32)
Weight loss (269)
Women's health (16)
Worklife (11)
Date
Today (120)
Last 7 days (620)
Last 30 days (1960)
Last 365 days (24758)
2025 (8076)
2024 (26451)
2023 (29743)
2022 (39221)
2021 (42077)
2020 (40254)
2019 (33344)
2018 (25548)
2017 (25253)
2016 (24090)
2015 (27823)
2014 (22008)
2013 (18296)
2012 (19516)
2011 (20307)
2010 (18643)
Location
Africa (693)
Alabama (37)
Alaska (3)
Arizona (122)
Arkansas (7)
Asia (33717)
Australia (5415)
California (4272)
Canada (1575)
China (437)
Colorado (192)
Connecticut (187)
Delaware (118)
Europe (74788)
Florida (680)
Georgia (135)
Hawaii (1)
Idaho (32)
Illinois (381)
India (26)
Indiana (229)
Iowa (8)
Japan (139)
Kansas (77)
Kentucky (16)
Louisiana (10)
Maine (28)
Maryland (725)
Massachusetts (3236)
Michigan (116)
Minnesota (187)
Mississippi (1)
Missouri (57)
Montana (23)
Nebraska (12)
Nevada (41)
New Hampshire (27)
New Jersey (1366)
New Mexico (18)
New York (1279)
North Carolina (704)
North Dakota (5)
Northern California (1891)
Ohio (135)
Oklahoma (7)
Oregon (22)
Pennsylvania (961)
Puerto Rico (11)
Rhode Island (18)
South America (998)
South Carolina (11)
South Dakota (1)
Southern California (1618)
Tennessee (60)
Texas (551)
United States (16242)
Utah (101)
Virginia (124)
Washington D.C. (46)
Washington State (363)
West Virginia (2)
Wisconsin (36)
507,183 Results for "phenex pharmaceuticals ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
OrsoBio Announces Acquisition of LXR Inverse Agonist Program for Treatment of Severe Dyslipidemias from Phenex Pharmaceuticals
OrsoBio, Inc. today announced its acquisition of assets relating to the Liver X Receptor (LXR) inverse agonist program from Phenex Pharmaceuticals, including lead candidate TLC-2716 and associated intellectual property.
November 2, 2022
·
5 min read
Press Releases
Additional Member for the Board of Directors of Bachem Holding AG
April 3, 2025
·
3 min read
Press Releases
Bacteria in Our Aging Guts Can Elevate Risk of Leukemia
April 24, 2025
·
7 min read
Press Releases
Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)
January 8, 2025
·
7 min read
Press Releases
Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines
February 26, 2025
·
7 min read
Press Releases
Luminopia Announces FDA Clearance for Patients with Amblyopia Aged 8 to 12 Years
April 22, 2025
·
5 min read
Deals
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
MorphoSys AG announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo Germany AG.
June 20, 2024
·
4 min read
Press Releases
Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)
February 18, 2025
·
5 min read
Press Releases
Compremium AG Appoints Dr. Kolaleh Eskandanian to Lead New Division of Pediatrics and Special Populations
April 24, 2025
·
4 min read
Biotech Bay
Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for the Treatment of PFIC in Patients Three Months of Age and Older
Mirum Pharmaceuticals, Inc. has adopted a positive opinion of LIVMARLI® (maralixibat) oral solution for the treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) in patients three months of age and older.
May 31, 2024
·
8 min read
1 of 50,719
Next
